{"name":"Avanir Pharmaceuticals","slug":"avanir-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":115029000,"revenueGrowth":52.6,"grossMargin":0,"rdSpend":44004000,"netIncome":-50436000,"cash":306983000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2014"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Neurodex","genericName":"Neurodex","slug":"neurodex","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Neurodex","genericName":"Neurodex","slug":"neurodex","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBoWEd2UndRdG1vMV9XUVpFWnYxWndEUVJGU2NGNkxBTUoxTWNNQzZ1MHF3TE9pbkFtQUpmckF4V3dsZTRzWlNUY3NZRjMxN1ZfaWxZ?oc=5","date":"2025-07-16","type":"regulatory","source":"FirstWord Pharma","summary":"Ahead of adcom for Otsuka's PTSD drug, FDA flags conflicting pivotal results - FirstWord Pharma","headline":"Ahead of adcom for Otsuka's PTSD drug, FDA flags conflicting pivotal results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE5ycV9ubVJ2blhPMGctTGpOM20zczQxcld4RXp2TXM3NW8xTzQ4TWhta3kwZW1abVlCX094VXY1MmFUZUVIMTVFQjVHbklxeEZxX2dtWnBfS25FTnpqM3ZlcUluYXhMQ25UbHE4ZWxvTVAwZnJMd3c?oc=5","date":"2023-06-07","type":"pipeline","source":"corporatecomplianceinsights.com","summary":"Hard Pill to Swallow: Sorting Out Conflicting Guidance for Pharma Speaker Programs - corporatecomplianceinsights.com","headline":"Hard Pill to Swallow: Sorting Out Conflicting Guidance for Pharma Speaker Programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQcHB0aW5Zd1BqSTZVS2VsWVpKdERROFFZbzQ5SnZhdi12Q21XWnBsNG1PU0xiRGgzNTVDY0lVYkU4c1I4cDNKWmN5eHN2Y1A1ZmY3ek9VaDJSbEJRS2VzYzBFaDJJNUttSG9Zdkp5ZFNnLU1zT2I3blhJVGNBRjFWU3U2UUtKVVhvcjk1OHBSQW1vbzlzcy1oaWx0NmRMVnpnQjhfd2lvUkVhQjF4MlRVdnh2WEE1WndMRUVYbFhOSnpyNHF6VnJndW9R?oc=5","date":"2023-04-24","type":"pipeline","source":"Cleveland.com","summary":"Ex-pharmacy rep sentenced to prison for paying kickbacks to Cleveland doctors - Cleveland.com","headline":"Ex-pharmacy rep sentenced to prison for paying kickbacks to Cleveland doctors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOXzVwazBiQXNSQi1DRlFXbllEX25mWWFLdTk4TFBNbWhjcFRoUW5Gblp5V3B5b1VwOG5GYWZvUW1zTFBzcnNaeF85Y0s3RHdkQi1EWDZVdVpxRHdJdHV6TmRlamJ6UWs2Wjh6dVNnVVpxeVVKc3NHMlpzenZMelpFMlJKdU11N0g1QUhRX0NLWjdkM1FaMkJIUG5KUDFSWjZkRUY2b1h6ZTZ2QkdORWg3ZQ?oc=5","date":"2022-11-02","type":"pipeline","source":"Fierce Pharma","summary":"Avanir, Strides are laying off US employees as Sanofi eyes early retirements in Korea: report - Fierce Pharma","headline":"Avanir, Strides are laying off US employees as Sanofi eyes early retirements in Korea: report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBKOFBNWlZ6XzZKYktMREY1bEFRUEpjSzFNYjZkV01RWFJOYXM5WTJkdVJYMEVuM0V1eWthRTFoeDhfWmItalJESGN0clNlVFJUNDlTa0ZWWVN5bTNxVnVXX3FfWjVLaHU0T2Q1aw?oc=5","date":"2022-01-12","type":"pipeline","source":"Pharma Voice","summary":"Talent Pool - Pharma Voice","headline":"Talent Pool","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBhWldHdThGX1V4QWFPdENXcGNjWk03SERZVm5zenJlblBzdTJKZkRaMnBtY08xajQ5QWtUdUVRbGNhNzBrNzRVQ1BjUmtnSmZxX01MbmJGS25CTktfenFJbUw1V1hNWEd6c1V3eXVvS2RvdnJfemt2blEtMA?oc=5","date":"2020-08-02","type":"pipeline","source":"Pharmaceutical Executive","summary":"Pharm Exec's Emerging Pharma Leaders 2020 - Pharmaceutical Executive","headline":"Pharm Exec's Emerging Pharma Leaders 2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOSnRGS0dHVlBEM1lEcHpVbFZiM3hRaEVVVllwWFBDWHN0dUgweV9HdURETHhDS3N4dTVLRXQzVThWYUloRDAwdWNGQUN2X3FNUTBLR3lKOTNxa3NPc1l0NC1tNERWbEFCWTVUN282Wnh6N1JwRXVkVV9BU0pZQ2ZxVFNTTXNuczBaTERXV3IwNHVHYkZHLU85ZG1keFlRY25jSllwa0ZnQk8?oc=5","date":"2020-01-10","type":"pipeline","source":"Fierce Pharma","summary":"Otsuka's Avanir unit plots 140 layoffs in wake of $116M Nuedexta settlement - Fierce Pharma","headline":"Otsuka's Avanir unit plots 140 layoffs in wake of $116M Nuedexta settlement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPeXpjVlIwSDBVczNreWVwVHUzMVVOOVR3aWRTczJ1TDZ5QlE1ZVdOb2Izd0J0VVhHN3V5ajRrSkdmX0J3bW5VUzlCNjNNZ1BQVlIwc01QSVhqVU1xYjR2Y1E2MWY0alI2a2ZMMUNBbWVSM3lGX2lEdWtqOGt2QWhiN1lZZko2c3lsZkdYX1lWUV9xZ3RRQjRSU2xZV0hwckdOanBlTllIMFVGN1ppRjg4dWJ2MVJrOFhmYlJwMTFQSzdKT285SjlzWUd5N2VCR0ZXdWV6UklR?oc=5","date":"2019-10-17","type":"pipeline","source":"ProPublica","summary":"We Found Over 700 Doctors Who Were Paid More Than a Million Dollars by Drug and Medical Device Companies - ProPublica","headline":"We Found Over 700 Doctors Who Were Paid More Than a Million Dollars by Drug and Medical Device Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQYkxMVGs1YnFPeW5UaGV1LW41NkUtV2h2bjhHbGpLOXJJUE1nN1lza3kydGg0T0V5cWdCX3VMblJtZXhacjFLNHVKLXo2a0JydVpGSHhPNGhQR0ZJZmlnRW95Y1NCenVaaXNTd1BXb0JQNkdoVjVJQTNLN2E4VUZuZWJ3ZUU?oc=5","date":"2019-10-16","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Emerging Pharma: Roivant Sciences on the Rise - DCAT Value Chain Insights","headline":"Emerging Pharma: Roivant Sciences on the Rise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQRXFGSTkwOXp1QnNCX2xqM2cwXzQ0bWtZeU1VYk8wUDhwTDVKUUpxTk5DdXVSa0RfRUtIdDN0UUpFMXpPSGxJaVJBQ2dra014azhVbl9uZ0FlUHVqRXIwcXpZeVhGOE1tLXAyMDVSdVlVa0U5cEhCVmY2dkhaWFVqRlcxTnY2eW9Ja05MclJfVU1aZEQtVDlVaUE3LTlXQnFyWWtsUQ?oc=5","date":"2017-05-16","type":"pipeline","source":"KFF Health News","summary":"Overwrought Marketing? Ads, Not Research, Create Some Pharma Best-Sellers - KFF Health News","headline":"Overwrought Marketing? Ads, Not Research, Create Some Pharma Best-Sellers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOME5BVmFtN2wtelhNZFU4NWFCeWtsVTRyaUVBUmNYY2RQSjBucVdHaVMwOXhnYml0dk8xTVl4Tm5iQld6RDBVMVdoODllVUg5eVdybzRZMUJhOHhETHhnNktqMUZOcnhpcENycXVXRXFqa29JYWZWZDdyTXpjMldGMDFTRTVRQjk3b0U2WHotSF9QbkRpVFRSekt4TThfR3NObG5UUFJrWVVSZkhHaDlkd2lwNUxvQQ?oc=5","date":"2014-12-03","type":"deal","source":"BioPharma Dive","summary":"Patent cliff ahead: Otsuka to buy Avanir for $3.5B and a slate of new products - BioPharma Dive","headline":"Patent cliff ahead: Otsuka to buy Avanir for $3.5B and a slate of new products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPbFlNV0l6NkpFUXExMXoyVURpanFSckZweXpXOG96QTRCSWtBbkNXcDRQdlRrTXhNbnhqLTUtXzJXc3RkNklIRTgyLVlzaGdGNW41NEdVc3lfYWhKSFNIZE42RnZ6SFhjb1RKdXVtZ2N6RHRnNEItR2llSU12bTRTODVzQThXNkE0dklj?oc=5","date":"2013-07-03","type":"pipeline","source":"Contract Pharma","summary":"Avanir, OptiNose in Drug Delivery Pact - Contract Pharma","headline":"Avanir, OptiNose in Drug Delivery Pact","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":115029000,"revenuePeriod":"2014-09-30","revenueHistory":[{"value":115029000,"period":"2014-09-30"},{"value":75365884,"period":"2013-09-30"},{"value":75366000,"period":"2013-09-30"},{"value":41275073,"period":"2012-09-30"},{"value":41275000,"period":"2012-09-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":44004000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-50436000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":306983000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}